WhiteSands Treatment Center Publishes New Resource on Cognitive Recovery After Stopping Gabapentin

Fort Myers, Florida - March 04, 2026 - PRESSADVANTAGE - WhiteSands Treatment Center has published a new educational ...

Muse Treatment Publishes In-Depth New Resource Examining the Dangers of Fentanyl-Laced Meth and Public Health Implications

LOS ANGELES, CA - March 04, 2026 - PRESSADVANTAGE - Muse Treatment Alcohol & Drug Rehab Los Angeles has published a ...

Alcohol abstinence enables regeneration even in advanced liver cirrhosis

Consistent and permanent abstinence from alcohol can lead to the regression of existing liver-related complications, even in ...
The BMJ

Metabolic medicines and addiction: what GLP-1 receptor agonists might add to substance use care

Clinical trials and equitable care pathways are needed to build on early evidence of benefit Substance use disorders (SUDs) are common and burdensome for patients, families, and health systems,12 yet ...

GLP-1 drugs may fight addiction across every major substance, according to a study of 600,000 people

A patient of mine, a veteran who had tried to quit smoking for over a decade, told me that after he started a GLP-1 drug for his diabetes, he lost interest in cigarettes. He didn’t use a patch. He ...